RE:RE:RE:WELL Health Technologies is a Buy, says Eight Capital I have never heard of Eight Capital. Must be a very small investment firm. They fact that they would give a 5x sales to WELL seems a bit too much of a promotion rather than an honest forecast. I appreciate honest and unbiased opinions. Like the one you mentioned last time about the Financials of WELL.
CRH is a company that has been around for a long time. It's not a growth or Tech company and therefore should not be valued at 5x sales. I understand how WELL would use it to backfill it's Earnings but can't justify giving CRH a 5x sales valuation. Typically for a company to have such generous P/S validation, it needs to have serious growth ( not just bought revenue but organic type) and very unique technology. Please explain which of the two does CRH have ?
I will read a bit about Eight Capital to understand who they are but if they are involved in WELL's previous financing or have other business dealings with WELL, I am sure anyone would agree that their opinion regarding stock price is severely favourable.
can you please let me know which company that is considered comparable to WELL ( mixed of clinics and similar assets in Telehealth) are getting anything close to 5x sales valuations ? Even models in USA would be a good example. Thanks